Fingerprint
Dive into the research topics of 'A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424
Victoria K Woodcock, Sally Clive, Richard H Wilson, Vicky M Coyle, Michael R L Stratford, Lisa K Folkes, Richard Eastell, Claire Barton, Paul Jones, Shamim Kazmi-Stokes, Helen Turner, Sarah Halford, Adrian L Harris, Mark R Middleton
Research output: Contribution to journal › Article › peer-review
10
Citations
(Scopus)
246
Downloads
(Pure)